Copyright 2024
Medical Security Card Company, LLC
All Rights Reserved
WellRx will never sell your personal information. Period. By signing up I agree to WellRx's terms of use and privacy policy.
FOSAPREPITANT/Emend (fos ap RE pi tant) prevents nausea and vomiting from chemotherapy. It works by blocking substances in your body that may cause nausea and vomiting. It belongs to a class of medications called antiemetics.
Fosaprepitant dimeglumine 245.3mg, Powder for solution for injection
Grapefruit juice
· Severity: Major
· Notes for Consumers: Do not take Aprepitant, Fosaprepitant with grapefruit juice. Increased side effects may be observed if these drugs are given together. Discuss possible alternative options with your health care provider.
· Notes for Professionals: Avoid the concomitant use of aprepitant, fosaprepitant with grapefruit juice due to substantially increased exposure of aprepitant. After administration, fosaprepitant is rapidly converted to aprepitant. Grapefruit juice is a strong CYP3A4 inhibitor and aprepitant is a CYP3A4 substrate. Coadministration of a single oral dose of aprepitant on day 5 of a 10-day ketoconazole regimen (strong CYP3A4 inhibitor) increased the aprepitant AUC approximately 5-fold, and increased the mean terminal half-life by approximately 3-fold.
You need to log into the site to use this feature
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Manufacturer Coupons and Offers Available
Number of Uses:
fosaprepitant dimeglumine
150 MG | VIAL | 15 mls
You need to log into the site to use this feature
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
You will be redirected to your program in 5 seconds.
Our Terms and Conditions and Privacy Policy have recently been updated.
By declining you will be logged out of your account